Wolverine Trading
CODX

Wolverine Trading’s Co-Diagnostics CODX Stock Holding History

Wolverine Trading’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-550
Closed -$11.5K – 4875
2024
Q4 		$11.5K Buy
+550
New +$17.4K ﹤0.01% 5147
2023
Q2 		– Sell
-373
Closed -$17K – 4327
2023
Q1 		$17K Sell
373
-170
-31% -$13.6K ﹤0.01% 4027
2022
Q4 		$41K Buy
+543
New +$50.8K ﹤0.01% 3614
2022
Q3 		– Sell
-380
Closed -$61K – 4682
2022
Q2 		$61K Sell
380
-690
-64% -$105K ﹤0.01% 4010
2022
Q1 		$204K Sell
1,070
-827
-44% -$171K ﹤0.01% 4401
2021
Q4 		$517K Buy
1,897
+944
+99% +$248K ﹤0.01% 3410
2021
Q3 		$279K Sell
953
-30
-3% -$8.76K ﹤0.01% 4819
2021
Q2 		$263K Sell
983
-197
-17% -$50.6K ﹤0.01% 4616
2021
Q1 		$302K Sell
1,180
-1,177
-50% -$470K ﹤0.01% 4455
2020
Q4 		$688K Buy
2,357
+607
+35% +$225K ﹤0.01% 2800
2020
Q3 		$731K Buy
1,750
+250
+17% +$128K ﹤0.01% 2384
2020
Q2 		$785K Buy
+1,500
New +$685K ﹤0.01% 2251

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Wolverine Trading's CODX Position: Q1 2025 in Review

Wolverine Trading sold out of Co-Diagnostics (CODX) in Q1 2025, closing a stake of 451 shares — an estimated $9.46K sold.

Wolverine Trading first reported a position in CODX in Q2 2020 and held it in 8 quarters. The position peaked at $302K in Q3 2020. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2025.

  • Wolverine Trading reported no remaining Co-Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 451 Co-Diagnostics shares in Q1 2025, an estimated $9.46K.
  • Wolverine Trading first reported a position in Co-Diagnostics in Q2 2020 and held it in 8 quarters.
  • Wolverine Trading's Co-Diagnostics position peaked at $302K in Q3 2020.
  • 38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.